Morepen Lab’s share price rises sharply following the company’s Q1 results, with multiple reports saying the stock gains around 20% and reaches the exchange’s upper circuit. The move occurs immediately after Morepen Lab declares its first-quarter financial results, which show net profit increasing roughly five-fold compared with the year-ago period, prompting investors to bid up the stock. One report characterizes the rally as nearly 20%, while another states the increase is about 20%, but both attribute the surge to the Q1 net profit jump. The articles describe the stock’s advance as rapid and limit-hit, indicating strong buying pressure on the day the results are released. No additional operational details, guidance figures, or broader market context are included in the provided summaries, so the key common elements remain the timing of the move after Q1 results and the reported five-fold increase in net profit that drives the near-20% price reaction.